INTS vs SNOW
Intensity Therapeutics, Inc. Common stock (INTS) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
INTS does not have a complete income-statement cache yet.
Latest reported SNOW revenue for 2026-01-31 was $4.68B. Net income was -$1.33B. Revenue was up 29.2% from 2025-01-31 to 2026-01-31. SNOW currently screens at market cap $73.90B.
INTS currently screens at market cap $7.7M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the INTS and SNOW stock pages for the full models.
Not investment advice.